Pfizer and German partner BioNTech, as well as Moderna, currently supply such vaccines to the European Union.
Following a thorough review of many studies, the European Union's drug regulator concluded on Tuesday that COVID-19 vaccinations manufactured with mRNA technology do not cause pregnancy complications for expectant mothers or their newborns. According to the European Medicines Agency (EMA), a review of trials covering about 65,000 pregnancies at various stages found no evidence of an increased risk of complications, miscarriages, premature deliveries, or serious side effects on unborn kids from mRNA shots. Such vaccines are now supplied to the European Union by Pfizer and its German partner BioNTech, as well as Moderna. "The benefits of receiving mRNA COVID-19 vaccines during pregnancy outweigh any possible risks for expectant mothers and unborn babies," the agency said.
The EMA noted that the data had significant limitations, but that the results were consistent across studies. COVID-19 shots are just as effective in reducing the risk of hospitalization and mortality in pregnant people as they are in non-pregnant people, according to an internal review. Several EU countries have already endorsed the use of COVID-19 vaccines for pregnant people, and the EMA's backing of mRNA shots is likely to bolster vaccination campaigns in smaller nations that rely on the regulator's scientific expertise. According to the World Health Organization (WHO) there have been 326,279,424 confirmed cases of COVID-19, including 5,536,609 deaths, reported as of the 17th of January 2022. As of 16 January 2022, a total of 9,395,059,118 vaccine doses have been administered.